BlackRock Finance, Inc. - NEOGENOMICS INC ownership

NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 257 filers reported holding NEOGENOMICS INC in Q2 2024. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Finance, Inc. ownership history of NEOGENOMICS INC
ValueSharesWeighting
Q2 2024$272,823,925
-12.6%
19,670,074
-0.9%
0.01%
-14.3%
Q1 2024$312,055,585
-3.5%
19,850,864
-0.7%
0.01%
-12.5%
Q4 2023$323,292,467
+30.7%
19,980,993
-0.6%
0.01%
+14.3%
Q3 2023$247,265,769
-25.9%
20,102,908
-3.2%
0.01%
-22.2%
Q2 2023$333,873,726
-10.0%
20,776,212
-2.5%
0.01%
-18.2%
Q1 2023$370,978,898
+83.1%
21,308,380
-2.8%
0.01%
+83.3%
Q4 2022$202,665,329
+11.5%
21,933,477
+3.9%
0.01%0.0%
Q3 2022$181,750,000
+6.0%
21,109,182
+0.4%
0.01%
+20.0%
Q2 2022$171,396,000
-28.0%
21,030,127
+7.4%
0.01%
-16.7%
Q1 2022$238,018,000
-63.9%
19,590,049
+1.4%
0.01%
-64.7%
Q4 2021$659,480,000
-27.1%
19,328,254
+3.0%
0.02%
-32.0%
Q3 2021$904,947,000
+7.0%
18,759,215
+0.2%
0.02%
+4.2%
Q2 2021$845,695,000
-6.4%
18,722,505
-0.1%
0.02%
-11.1%
Q1 2021$903,886,000
-2.7%
18,741,126
+8.7%
0.03%
-10.0%
Q4 2020$928,557,000
+53.6%
17,246,570
+5.3%
0.03%
+36.4%
Q3 2020$604,445,000
+17.0%
16,385,080
-1.7%
0.02%
+4.8%
Q2 2020$516,629,000
+22.2%
16,676,235
+8.9%
0.02%0.0%
Q1 2020$422,750,000
-7.3%
15,311,504
-1.8%
0.02%
+23.5%
Q4 2019$455,982,000
+55.7%
15,589,132
+1.8%
0.02%
+41.7%
Q3 2019$292,842,000
-10.6%
15,315,991
+2.6%
0.01%
-14.3%
Q2 2019$327,462,000
+15.8%
14,925,327
+8.0%
0.01%
+7.7%
Q1 2019$282,861,000
+306.4%
13,825,064
+150.5%
0.01%
+225.0%
Q4 2018$69,603,000
-10.7%
5,519,647
+8.7%
0.00%
+33.3%
Q3 2018$77,960,000
+43.3%
5,079,026
+22.4%
0.00%0.0%
Q2 2018$54,397,000
+68.1%
4,149,329
+4.7%
0.00%
+50.0%
Q1 2018$32,354,000
-7.6%
3,964,943
+0.3%
0.00%0.0%
Q4 2017$35,022,000
-19.3%
3,952,796
+1.4%
0.00%0.0%
Q3 2017$43,381,000
+41.5%
3,897,798
+13.9%
0.00%0.0%
Q2 2017$30,653,000
+16.7%
3,421,117
+2.7%
0.00%
+100.0%
Q1 2017$26,276,000
+72888.9%
3,330,256
+78240.5%
0.00%
Q4 2016$36,000
-7.7%
4,251
-10.2%
0.00%
Q3 2016$39,000
+11.4%
4,735
+7.2%
0.00%
Q2 2016$35,000
+40.0%
4,418
+19.5%
0.00%
Q1 2016$25,000
+127.3%
3,696
+159.6%
0.00%
Q4 2015$11,000
+37.5%
1,4240.0%0.00%
Q3 2015$8,0000.0%1,4240.0%0.00%
Q2 2015$8,0001,4240.00%
Other shareholders
NEOGENOMICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 567,607$1,703,0001.22%
Curi RMB Capital, LLC 3,878,387$11,635,0000.84%
KOPP INVESTMENT ADVISORS LLC 739,495$2,218,0000.82%
BARD ASSOCIATES INC 531,700$1,595,0000.71%
THB ASSET MANAGEMENT 1,516,990$4,550,0000.28%
Cortina Asset Management, LLC 2,089,792$6,269,0000.24%
Legacy Capital Partners, Inc. 70,000$210,0000.16%
FineMark National Bank & Trust 200,250$601,0000.15%
CASTLEARK MANAGEMENT LLC 572,400$2,982,0000.08%
Granite Investment Partners, LLC 110,695$332,0000.05%
View complete list of NEOGENOMICS INC shareholders